AstraZeneca (GB:AZN) has released an update.
AstraZeneca PLC has announced that as of August 31, 2024, the company’s total issued share capital with voting rights comprises 1,550,286,637 ordinary shares, with none held in treasury. This figure is crucial for shareholders to calculate their notification requirements for changes in shareholdings under the UK’s Financial Conduct Authority rules. AstraZeneca is a leading biopharmaceutical company that markets its prescription medicines globally across various therapeutic areas.
For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.
